class=”sc-97fd9fa8-0 jNFKxv”>
More than 1000 drugs are no longer available in Switzerland. The prices of new drugs are increasing rapidly. Individual therapies cost millions.
For Beat Ringger (67), author of “Pharma fürs Volk,” these are symptoms of a systemic crisis: “Supply is in grave danger because pharmaceutical companies only serve shareholders – and they are demanding more and more.” They would therefore withdraw from central areas such as antibiotic development. “The result is a global drug crisis.”
Now Ringger wants to take countermeasures with the “Medicine for all” organization. Their purpose: the drug supply of the public. Ringger wants to start in Basel. There, Novartis boss Vas Narasimhan (46) Sandoz wants to leave the credits division. Next week “Medicine for all” will make him an offer. “We’re only offering a symbolic franc,” says Ringger.
Why should the group respond to this? “Novartis has made a profit of about 200 billion francs since 2001,” says Ringger. “The money comes from taxpayers and insurers. Now the group must give something to the public.”
Ringger gets political support from LinksGrün. SP National Assembly Member Barbara Gysi (58) says: “Pharmaceuticals must also be developed and produced in this country – at affordable prices, without huge profits.”
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
